Keyword: Antibody-Drug Conjugates (ADC)
Plant Construction & Process Technology
12.09.2016
-
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
Strategy & Management
08.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
Markets & Companies
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
News
20.11.2015
- Piramal Healthcare UK Ltd., a subsidiary of the Indian Piramal group, is spending £2 million to expand its manufacturing base for antibody drug conjugates at Grangemouth, Scotland...
News
24.09.2014
- Switzerland's Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, and US biopharmaceuticals producer Sutro Biopharma have agreed a collaboration and license agreement...
News
08.08.2014
- Carbogen Amcis, Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, has announced plans to take over operations of a high...
News
25.06.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, and US company Mersana Therapeutics, based in Cambridge, Massachusetts, have agreed to collaborate on...
News
14.10.2013
- Swiss drug maker Roche is to invest 800 million Swiss francs ($880 million) in its global manufacturing facilities over the next five years, creating 500 jobs, as it prepares for...
